<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7915123" creator="Hitomi MASUDA"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7915123</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Appraisal of <term id="T1" lex="potential_therapeutic_index" sem="Other">potential therapeutic index</term> of <term id="T2" lex="antioxidant" sem="Organic_compound_other">antioxidants</term> on the basis of their in vitro effects on <term id="T3" lex="HIV_replication" sem="Other"><term id="T4" lex="HIV" sem="Virus">HIV</term> replication</term> in <term id="T5" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T6" lex="interleukin_2-induced_lymphocyte_proliferation" sem="Other"><term id="T7" lex="interleukin_2" sem="Protein_molecule">interleukin 2</term>-induced <term id="A1" sem="Cell_natural">lymphocyte</term> <term id="T8" lex="proliferation" sem="Other">proliferation</term></term>.</sentence>
<event KT="Other" id="E1">
<type class="Cellular_physiological_process"/>
<theme idref="A1"/>
<clue>Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte <clueType>proliferation</clueType>.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T7"/>
<clue>Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-<clueType>induced</clueType> lymphocyte proliferation.</clue>
</event>
<event KT="Other" id="E3">
<type class="Viral_life_cycle"/>
<theme idref="T4"/>
<clue>Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV <clueType>replication</clueType> in monocytes and interleukin 2-induced lymphocyte proliferation.</clue>
</event>
<event KT="Investigation" id="E4" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="T2"/>
<clue><clueKT>Appraisal</clueKT> of potential therapeutic index of antioxidants on the basis of their in vitro <clueType>effects</clueType> <linkTheme>on</linkTheme> HIV replication <clueLoc>in monocytes</clueLoc> and interleukin 2-induced lymphocyte proliferation.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Antioxidant molecules have been suggested to be of therapeutic value in the treatment of <term id="T9" lex="HIV-infected_patient" sem="Multicellular_organism_natural"><term id="T10" lex="HIV" sem="Virus">HIV</term>-infected patients</term>.</sentence>
<sentence id="S3">To evaluate this possibility, we examined in vitro the effects of two types of <term id="A2" sem="Organic_compound_other">antioxidant</term> molecules in terms of inhibition of <term id="T11" lex="HIV_replication" sem="Other"><term id="T12" lex="HIV" sem="Virus">HIV</term> replication</term> in <term id="T13" lex="monocyte" sem="Cell_natural">monocytes</term>, one of the main reservoirs of <term id="T14" lex="HIV" sem="Virus">HIV</term>, and also in terms of modulation of the <term id="A3" sem="Other">immune competence</term> as measured by <term id="T15" lex="PBMC_proliferation" sem="Other"><term id="T16" lex="PBMC" sem="Cell_natural">PBMC</term> <term id="T17" lex="proliferation" sem="Other">proliferation</term></term>.</sentence>
<event KT="Other" id="E5">
<type class="Viral_life_cycle"/>
<theme idref="T12"/>
<clue>To evaluate this possibility, we examined in vitro the effects of two types of antioxidant molecules in terms of inhibition of HIV <clueType>replication</clueType> in monocytes, one of the main reservoirs of HIV, and also in terms of modulation of the immune competence as measured by PBMC proliferation.</clue>
</event>
<event KT="Other" id="E6">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<clue>To evaluate this possibility, we examined in vitro the effects of two types of antioxidant molecules in terms of <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV replication in monocytes, one of the main reservoirs of HIV, and also in terms of modulation of the immune competence as measured by PBMC proliferation.</clue>
</event>
<event KT="Investigation" id="E7" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E6"/>
<cause idref="A2"/>
<clue><clueKT>To evaluate</clueKT> this possibility, we <clueKT>examined</clueKT> in vitro the <clueType>effects</clueType> <linkCause>of</linkCause> two types of antioxidant molecules <linkTheme>in terms of</linkTheme> inhibition of HIV replication <clueLoc>in monocytes</clueLoc>, one of the main reservoirs of HIV, and also in terms of modulation of the immune competence as measured by PBMC proliferation.</clue>
</event>
<event KT="Other" id="E8">
<type class="Regulation"/>
<theme idref="A3"/>
<clue>To evaluate this possibility, we examined in vitro the effects of two types of antioxidant molecules in terms of inhibition of HIV replication in monocytes, one of the main reservoirs of HIV, and also in terms of <clueType>modulation</clueType> <linkTheme>of</linkTheme> the immune competence as measured by PBMC proliferation.</clue>
</event>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="A2"/>
<clue><clueKT>To evaluate</clueKT> this possibility, we <clueKT>examined</clueKT> in vitro the <clueType>effects</clueType> <linkCause>of</linkCause> two types of antioxidant molecules in terms of inhibition of HIV replication in monocytes, one of the main reservoirs of HIV, and also <linkTheme>in terms of</linkTheme> modulation of the immune competence <clueExperiment>as measured by PBMC proliferation</clueExperiment>.</clue>
</event>
<sentence id="S4">We tested the effects of <term id="T18" lex="BHA" sem="Organic_compound_other">BHA</term>, a <term id="T19" lex="phenolic,_lipid-soluble,_chain-breaking_antioxidant" sem="Organic_compound_other">phenolic, lipid-soluble, chain-breaking antioxidant</term>, and <term id="T20" lex="NAC" sem="Organic_compound_other">NAC</term>, a known <term id="T21" lex="glutathione_precursor" sem="Organic_compound_other"><term id="T22" lex="glutathione" sem="Peptide">glutathione</term> precursor</term> with some direct <term id="T23" lex="free-radical_scavenging_property" sem="Other">free-radical scavenging properties</term> as well, on the regulation of <term id="T24" lex="HIV-1_expression" sem="Other"><term id="T25" lex="HIV-1" sem="Virus"><term id="T26" lex="HIV" sem="Virus">HIV</term>-1</term> expression</term> in latently infected <term id="T27" lex="U1_cell" sem="Cell_cultured">U1 cells</term> and in productively and chronically infected <term id="T28" lex="U937_cell" sem="Cell_cultured">U937 cells</term>.</sentence>
<event KT="Other" id="E10">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue>We tested the effects of BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, on the regulation of HIV-1 <clueType>expression</clueType> in latently infected U1 cells and in productively and chronically infected U937 cells.</clue>
</event>
<event KT="Other" id="E11">
<type class="Regulation"/>
<theme idref="E10"/>
<clue>We tested the effects of BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, on the <clueType>regulation</clueType> <linkTheme>of</linkTheme> HIV-1 expression in latently infected U1 cells and in productively and chronically infected U937 cells.</clue>
</event>
<event KT="Investigation" id="E12" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T18"/>
<clue>We <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, <linkTheme>on</linkTheme> the regulation of HIV-1 expression <clueLoc>in latently infected U1 cells</clueLoc> and in productively and chronically infected U937 cells.</clue>
</event>
<event KT="Investigation" id="E112" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T18"/>
<clue>We <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, <linkTheme>on</linkTheme> the regulation of HIV-1 expression in latently infected U1 cells and <clueLoc>in productively</clueLoc> and chronically <clueLoc>infected U937 cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E212" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T18"/>
<clue>We <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, <linkTheme>on</linkTheme> the regulation of HIV-1 expression in latently infected U1 cells and <clueLoc>in</clueLoc> productively and <clueLoc>chronically infected U937 cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T20"/>
<clue>We <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, <linkTheme>on</linkTheme> the regulation of HIV-1 expression <clueLoc>in latently infected U1 cells</clueLoc> and in productively and chronically infected U937 cells.</clue>
</event>
<event KT="Investigation" id="E113" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T20"/>
<clue>We <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, <linkTheme>on</linkTheme> the regulation of HIV-1 expression in latently infected U1 cells and <clueLoc>in productively</clueLoc> and chronically <clueLoc>infected U937 cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E213" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T20"/>
<clue>We <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> BHA, a phenolic, lipid-soluble, chain-breaking antioxidant, and NAC, a known glutathione precursor with some direct free-radical scavenging properties as well, <linkTheme>on</linkTheme> the regulation of HIV-1 expression in latently infected U1 cells and <clueLoc>in</clueLoc> productively and <clueLoc>chronically infected U937 cells</clueLoc>.</clue>
</event>
<sentence id="S5">Both <term id="T29" lex="antioxidant" sem="Organic_compound_other">antioxidants</term> inhibited <cons id="T30" lex="(OR TNF-induced_NF-kappa_B_activity PMA-induced_NF-kappa_B_activity)" sem="(OR Other Other)"><term id="T31" lex="TNF-*" sem="Other"><term id="T32" lex="TNF" sem="Protein_family_or_group">TNF</term></term>- or <term id="T33" lex="PMA-*" sem="Other">PMA-</term><term id="T34" lex="*induced_NF-kappa_B_activity" sem="Other">induced <term id="T35" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activity</term></cons> in <term id="T36" lex="U1_cell" sem="Cell_cultured">U1 cells</term>, as well as the sustained <term id="T37" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activity permanently induced by the virus itself in chronically <term id="T38" lex="HIV" sem="Virus">HIV</term>-infected <term id="T39" lex="U937_cell" sem="Cell_cultured">U937 cells</term>.</sentence>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="T32"/>
<clue>Both antioxidants inhibited TNF- or PMA-<clueType>induced</clueType> NF-kappa B activity in U1 cells, as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-infected U937 cells.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="T33"/>
<clue>Both antioxidants inhibited TNF- or PMA-<clueType>induced</clueType> NF-kappa B activity in U1 cells, as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-infected U937 cells.</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T18"/>
<clue><corefCause>Both antioxidants</corefCause> <clueType>inhibited</clueType> TNF- or PMA-induced NF-kappa B activity <clueLoc>in U1 cells</clueLoc>, as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-infected U937 cells.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T18"/>
<clue><corefCause>Both antioxidants</corefCause> <clueType>inhibited</clueType> TNF- or PMA-induced NF-kappa B activity <clueLoc>in U1 cells</clueLoc>, as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-infected U937 cells.</clue>
</event>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T20"/>
<clue><corefCause>Both antioxidants</corefCause> <clueType>inhibited</clueType> TNF- or PMA-induced NF-kappa B activity <clueLoc>in U1 cells</clueLoc>, as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-infected U937 cells.</clue>
</event>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T20"/>
<clue><corefCause>Both antioxidants</corefCause> <clueType>inhibited</clueType> TNF- or PMA-induced NF-kappa B activity <clueLoc>in U1 cells</clueLoc>, as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-infected U937 cells.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<cause idref="T38"/>
<clue>Both antioxidants inhibited TNF- or PMA-induced NF-kappa B activity in U1 cells, as well as the sustained NF-kappa B activity permanently <clueType>induced</clueType> <linkCause>by</linkCause> <corefCause>the virus</corefCause> itself in chronically HIV-infected U937 cells.</clue>
</event>
<event KT="Other" id="E21">
<type class="Initiation_of_viral_infection"/>
<theme idref="T38"/>
<theme idref="T39"/>
<clue>Both antioxidants inhibited TNF- or PMA-induced NF-kappa B activity in U1 cells, as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-<clueType>infected</clueType> U937 cells.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T18"/>
<clue><corefCause>Both antioxidants</corefCause> <clueType>inhibited</clueType> TNF- or PMA-induced NF-kappa B activity in U1 cells, as well as the sustained NF-kappa B activity permanently induced by the virus itself <clueLoc>in chronically HIV-infected U937 cells</clueLoc>.</clue>
</event>
<event id="E23">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T20"/>
<clue><corefCause>Both antioxidants</corefCause> <clueType>inhibited</clueType> TNF- or PMA-induced NF-kappa B activity in U1 cells, as well as the sustained NF-kappa B activity permanently induced by the virus itself <clueLoc>in chronically HIV-infected U937 cells</clueLoc>.</clue>
</event>
<sentence id="S6">This resulted in only a partial inhibition of <cons id="T40" lex="(OR TNF-_induced_HIV_replication PMA-_induced_HIV_replication)" sem="(OR Other Other)"><term id="T41" lex="TNF-*" sem="Other"><term id="T42" lex="TNF" sem="Protein_family_or_group">TNF</term></term>- or <term id="T43" lex="PMA-*" sem="Other">PMA-</term> <term id="T44" lex="*induced_HIV_replication" sem="Other">induced <term id="A5" sem="Virus">HIV</term> replication</term></cons> in <term id="T45" lex="U1_cell" sem="Cell_cultured">U1 cells</term>, and no detectable effect on <term id="T46" lex="HIV_replication" sem="Other"><term id="T47" lex="HIV" sem="Virus">HIV</term> replication</term> in <term id="T48" lex="chronically_infected_U937_cells" sem="Cell_cultured">chronically infected <term id="T49" lex="U937_cell" sem="Cell_cultured">U937 cells</term></term>.</sentence>
<event id="E200">
<type class="Viral_life_cycle"/>
<theme idref="A5"/>
<clue>This resulted in only a partial inhibition of TNF- or PMA- induced HIV <clueType>replication</clueType> in U1 cells, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<cause idref="T42"/>
<clue>This resulted in only a partial inhibition of TNF- or PMA- <clueType>induced</clueType> HIV replication in U1 cells, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<cause idref="T43"/>
<clue>This resulted in only a partial inhibition of TNF- or PMA- <clueType>induced</clueType> HIV replication in U1 cells, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E26">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E16"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E27">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E17"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E28">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E18"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E29">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E19"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E201">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E16"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E202">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E17"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E203">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E18"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event Manner="Low" id="E204">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E19"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> <clueManner>only a partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> TNF- or PMA- induced HIV replication <clueLoc>in U1 cells</clueLoc>, and no detectable effect on HIV replication in chronically infected U937 cells.</clue>
</event>
<event id="E30">
<type class="Initiation_of_viral_infection"/>
<theme idref="T47"/>
<theme idref="T49"/>
<clue>This resulted in only a partial inhibition of TNF- or PMA- induced HIV replication in U1 cells, and no detectable effect on HIV replication in chronically <clueType>infected</clueType> U937 cells.</clue>
</event>
<event id="E31">
<type class="Viral_life_cycle"/>
<theme idref="T47"/>
<clue>This resulted in only a partial inhibition of TNF- or PMA- induced HIV replication in U1 cells, and no detectable effect on HIV <clueType>replication</clueType> in chronically infected U937 cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Regulation"/>
<theme idref="E31"/>
<cause idref="E22"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> only a partial inhibition of TNF- or PMA- induced HIV replication in U1 cells, and <cluePolarity>no</cluePolarity> <clueKT>detectable</clueKT> <clueType>effect on</clueType> HIV replication <clueLoc>in chronically infected U937 cells</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E33">
<type class="Regulation"/>
<theme idref="E31"/>
<cause idref="E23"/>
<clue><corefCause>This</corefCause> <linkCause>resulted in</linkCause> only a partial inhibition of TNF- or PMA- induced HIV replication in U1 cells, and <cluePolarity>no</cluePolarity> <clueKT>detectable</clueKT> <clueType>effect on</clueType> HIV replication <clueLoc>in chronically infected U937 cells</clueLoc>.</clue>
</event>
<sentence id="S7">This may be the first limitation to potential antiviral effects of antioxidant therapies.</sentence>
<sentence id="S8">Another limitation is that <term id="A6" sem="Organic_compound_other">antioxidant</term> concentrations high enough to block <term id="T50" lex="NK-kappa_B_activation" sem="Other"><term id="T51" lex="NK-kappa_B" sem="Protein_molecule">NK-kappa B</term> activation</term> were shown to have a suppressive effect on <term id="T52" lex="immune_function" sem="Other">immune functions</term> <term id="T53" lex="in_vitro" sem="Other">in vitro</term>, because <term id="T54" lex="NAC" sem="Organic_compound_other">NAC</term> and <term id="T55" lex="BHA" sem="Organic_compound_other">BHA</term> blocked <term id="T56" lex="IL-2-induced_PBMC" sem="Cell_natural"><term id="T57" lex="IL-2" sem="Protein_molecule">IL-2</term>-induced <term id="A7" sem="Cell_natural">PBMC</term></term> <term id="T58" lex="proliferation" sem="Other">proliferation</term>.</sentence>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="T51"/>
<clue>Another limitation is that antioxidant concentrations high enough to block NK-kappa B <clueType>activation</clueType> were shown to have a suppressive effect on immune functions in vitro, because NAC and BHA blocked IL-2-induced PBMC proliferation.</clue>
</event>
<event KT="Other" id="E35">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="A6"/>
<clue>Another limitation is that antioxidant concentrations high enough to <clueType>block</clueType> NK-kappa B activation were shown to have a suppressive effect on immune functions in vitro, because NAC and BHA blocked IL-2-induced PBMC proliferation.</clue>
</event>
<event KT="Analysis" id="E36">
<type class="Negative_regulation"/>
<theme idref="T52"/>
<cause idref="E35"/>
<clue>Another limitation is that antioxidant concentrations high enough to block NK-kappa B activation were <clueKT>shown</clueKT> to <clueType>have</clueType> a <clueType>suppressive effect</clueType> <linkTheme>on</linkTheme> immune functions in vitro, because NAC and BHA blocked IL-2-induced PBMC proliferation.</clue>
</event>
<event KT="Other" id="E37">
<type class="Cellular_physiological_process"/>
<theme idref="A7"/>
<clue>Another limitation is that antioxidant concentrations high enough to block NK-kappa B activation were shown to have a suppressive effect on immune functions in vitro, because NAC and BHA blocked IL-2-induced PBMC <clueType>proliferation</clueType>.</clue>
</event>
<event KT="Other" id="E205">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T57"/>
<clue>Another limitation is that antioxidant concentrations high enough to block NK-kappa B activation were shown to have a suppressive effect on immune functions in vitro, because NAC and BHA blocked IL-2-<clueType>induced</clueType> PBMC proliferation.</clue>
</event>
<event id="E38">
<type class="Negative_regulation"/>
<theme idref="E205"/>
<cause idref="T54"/>
<clue>Another limitation is that antioxidant concentrations high enough to block NK-kappa B activation were shown to have a suppressive effect on immune functions in vitro, because NAC and BHA <clueType>blocked</clueType> IL-2-induced PBMC proliferation.</clue>
</event>
<event id="E39">
<type class="Negative_regulation"/>
<theme idref="E205"/>
<cause idref="T55"/>
<clue>Another limitation is that antioxidant concentrations high enough to block NK-kappa B activation were shown to have a suppressive effect on immune functions in vitro, because NAC and BHA <clueType>blocked</clueType> IL-2-induced PBMC proliferation.</clue>
</event>
<sentence id="S9">These data warrant prudence in the design of <term id="T59" lex="antioxidant-based_therapy" sem="Other">antioxidant-based therapies</term> aimed at suppressing <term id="T60" lex="HIV_replication" sem="Other"><term id="T61" lex="HIV" sem="Virus">HIV</term> replication</term>.</sentence>
<event KT="Other" id="E40">
<type class="Viral_life_cycle"/>
<theme idref="T61"/>
<clue>These data warrant prudence in the design of antioxidant-based therapies aimed at suppressing HIV <clueType>replication</clueType>.</clue>
</event>
<event KT="Investigation" id="E41" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T59"/>
<clue>These data warrant prudence in the design of antioxidant-based therapies <clueKT>aimed</clueKT> at <clueType>suppressing</clueType> HIV replication.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
